Janssen Teams Up With Forma On Tumor Metabolism
This article was originally published in The Pink Sheet Daily
Executive Summary
Forma has garnered a deal with J&J subsidiary Janssen Pharmaceuticals to develop and commercialize treatments for tumor metabolism.